Research Article: A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma
Introduction:
Hepatocellular carcinoma (HCC) is the fifth-most-common malignant cancer and the second leading cause of cancer-related mortality worldwide. HCC is a major public health problem in China, where the number of newly diagnosed cases of HCC each year accounts for approximately % of the worldwide total. Patients with early-stage HCC can often undergo radical treatments such as liver resection, liver transplantation, or radiofrequency ablation. However, because the early symptoms of HCC are very unspecific, over % of…
Read more